Last updated on November 2018

Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.


Brief description of study

EP0060 is a multicenter, open-label study to evaluate the safety and tolerability of intravenous (iv) Lacosamide (LCM) in pediatric subjects >= 1 month to < 17 years of age with epilepsy.

Clinical Study Identifier: NCT02710890

Contact Investigators or Research Sites near you

Start Over

Ep0060 003

Birmingham, AL United States
  Connect »

Ep0060 010

Little Rock, AR United States
  Connect »

Ep0060 008

Loxahatchee Groves, FL United States
  Connect »

Ep0060 013

Bethesda, MD United States
  Connect »

Ep0060 002

New Brunswick, NJ United States
  Connect »

Ep0060 006

Akron, OH United States
  Connect »

Ep0060 007

San Antonio, TX United States
  Connect »

Ep0060 001

Norfolk, VA United States
  Connect »

Ep0060 400

Budapest, Hungary
  Connect »

Ep0060 401

Debrecen, Hungary
  Connect »

Ep0060 004

Louisville, KY United States
  Connect »

Ep0060 009

Saint Paul, MN United States
  Connect »

Ep0060 014

Henderson, NV United States
  Connect »

Ep0060 012

Memphis, TN United States
  Connect »

Ep0060 005

Dallas, TX United States
  Connect »

Ep0060 141

Radeberg, Germany
  Connect »

Ep0060 503

Messina, Italy
  Connect »

Ep0060 220

Ivano-Frankivs'k, Ukraine
  Connect »

Ep0060 227

Zaporizhzhya, Ukraine
  Connect »

Ep0060 223

Vinnytsia, Ukraine
  Connect »

Ep0060 011

Cincinnati, OH United States
  Connect »

Ep0060 701

Kraków, Poland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.